QualityStocksNewsBreaks Archives - Page 310 of 1584

ThursdayMay 02, 2024 2:42 pm

QualityStocksNewsBreaks – VenHub Files Patent in ‘Landmark Achievement’ Marking New Era of Functionality, Versatility

VenHub, a division of Autonomous Solutions Inc., has filed a patent for its Expandable Structure Smart Units. The company called the filing a “landmark achievement in innovation” and noted that the versatile and adaptable technology used by the units establishes new standards in retail and expandable structures. According to the announcement, the proprietary new units “redefine deployable spaces with cutting-edge technology.” The units are equipped with advanced hydraulic systems for expansion and locking, and serve a broad array of retail environments, including mobile and fixed retail setups, shopping centers, lockers, mobile distribution centers, pharmaceutical centers, and e-commerce sales and distribution…

ThursdayMay 02, 2024 2:32 pm

QualityStocksNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q1 2024 Financial Results, Earnings Conference Call/Webcast

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, will be releasing its first-quarter 2024 financial results this month. The company announced that it will release the report, along with a business update, on May 14, 2024, after the U.S. markets close. The company has also scheduled a conference call and webcast to discuss the release; the call will begin at 5 p.m. ET, also on May 14. Those wishing to access the call can dial 877-407-0789 and use the conference…

ThursdayMay 02, 2024 2:25 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Announces Launch of Evolve(TM) Mouse to Control Mouse Infestations

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced the launch of Evolve(TM) Mouse. Evolve Mouse utilizes a breakthrough fertility solution to control mouse infestations. It is designated as a ‘minimum’ risk product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the environment. SenesTech will be accepting orders as of Monday, May 6, for shipment on or before May 15. According to the announcement, one of the company’s lead distributors and online retailers, DIY Pest Control, has already committed to a sizable preorder and will immediately add…

ThursdayMay 02, 2024 2:20 pm

QualityStocksNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Wins ~$2M Israel Airports Authority Contract

HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”), a developer of confidential computing cybersecurity solutions and services, is announcing a new contract awarded by the Israel Airports Authority. Valued at approximately $2 million, this three-year contract calls for HUB to provide supervision services and engineering design consultancy at all Israel Airports Authority sites. According to the announcement, this contract positions HUB to monitor key components vital for maintaining security and operational continuity at critical aviation sites across Israel. HUB achieved the contract against ten other leading competitors. “This contract underscores confidence in our operational excellence and our steadfast commitment to managing…

WednesdayMay 01, 2024 3:22 pm

QualityStocksNewsBreaks – PODFEST, Cutting Edge Events Names IBN as Official Media Partner for PODFEST Asia

PODFEST and its parent company, Cutting Edge Events, have selected InvestorBrandNetwork (“IBN”), a pioneer in corporate communications and content distribution, to be the official media partner for its upcoming PODFEST Asia. The in-person podcasting conference is slated for May 8, 2024, in Manila. PODFEST Asia is designed to provide a unique opportunity for participants to engage with podcast enthusiasts, gather insights from industry experts, explore the latest trends and discover potential synergies with seasoned podcasters and newcomers alike. The one-day event represents a collaborative effort between PODFEST, Podcast Network Asia and MGS Global Group. Recognized as the longest-running annual podcasting conference…

WednesdayMay 01, 2024 2:40 pm

QualityStocksNewsBreaks – Proof of Pitch Promises to Provide Unique Transformative Platform to Showcase Web3 Innovation

Proof of Pitch represents a ground-breaking shift from traditional pitch competitions, emerging as a transformative platform that uniquely combines artificial intelligence (AI) insights with the strategic acumen of the world’s leading Web3 venture capitalists. Proof of Pitch calls upon startups at the cutting edge of Web3 innovation to dazzle the industry’s titans, venture through the vanguard of technology, and stake a claim in the digital future. It promises to provide an unmatched opportunity for innovators to present their visionary ideas, drive their startups forward, make a lasting imprint in the realm of digital innovation, and transcend traditional pitch norms. The…

WednesdayMay 01, 2024 2:31 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Q1 2024 Earnings Release, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, today announced that it will provide a business update and release its financial results for the first quarter of 2024 following the close of the market on Monday, May 13, 2024. Cepton will hold a conference call and webcast that same day at 2:30 p.m. PT (5:30 p.m. ET). Interested parties should dial 1-877-423-9813 (toll-free) or 1-201-689-8573 (international) to join the live call and visit https://investors.cepton.com to access the webcast. A telephonic replay of the conference call will be available approximately three hours after the live…

WednesdayMay 01, 2024 2:26 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Spotlighted in a Recent ‘From Lab to Launch’ Podcast Release

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. Rob Etherington, President, Director and CEO of Clene, was featured in a recent release of From Lab to Launch, a podcast sharing the inspiring stories of founders, investors, scientists, engineers and pioneers in the life sciences sector. The podcast, hosted by Meg Sinclair, is available for on-demand listening on From Lab to Launch. During the interview, Etherington discussed Clene’s work to address the critical unmet medical…

WednesdayMay 01, 2024 2:17 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces $4.7M Warrant Exercise Agreement

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into a warrant exercise agreement with an existing accredited investor to exercise in full existing warrants. Specifically, the agreement is comprised of the purchase of 2,917,032 shares of common stock, as to 1,618,330 warrants exercised at an exercise price of $0.97 per share, and 1,298,702 warrants exercised at $2.185 per share; the shares and warrants were originally issued in October 2023 and February 2024, respectively. The company noted that following this exercise, there are no remaining warrants exercisable at $0.97 and 259,741 warrants unexercised at $2.185. According…

TuesdayApr 30, 2024 12:58 pm

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Enters Agreement to Conduct Clinical Trial to Assess Safety, Efficacy of unbuzzd(TM)

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, has entered into agreement with Florida-based Applied Science and Performance Institute (“ASPI”). The agreement outlines plans to conduct a randomized, double-blind, placebo-controlled crossover study designed to assess the safety and efficacy of FSD Pharma’s unbuzzd(TM). The study will be conducted with healthy volunteers in an induced state of alcohol intoxication. A unique dietary supplement with natural ingredients, vitamins and Generally Recognized as Safe (“GRAS”) ingredients, unbuzzd exhibits potential…

Site Search

Company Search

Category: QualityStocksNewsBreaks